We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.4B
AUM Growth
+$501M
Cap. Flow
-$544M
Cap. Flow %
-4.05%
Top 10 Hldgs %
33.24%
Holding
1,308
New
44
Increased
620
Reduced
282
Closed
30

Top Buys

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$154M
2
MAA icon
Mid-America Apartment Communities
MAA
+$127M
3
REG icon
Regency Centers
REG
+$81.4M
4
SOCL icon
Global X Social Media ETF
SOCL
+$76.1M
5
KIM icon
Kimco Realty
KIM
+$73.4M

Top Sells

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$187M
2
WPC icon
W.P. Carey
WPC
+$162M
3
WELL icon
Welltower
WELL
+$126M
4
OHI icon
Omega Healthcare
OHI
+$110M
5
PLD icon
Prologis
PLD
+$84.3M

Sector Composition

Rank Sector Weight
1 Real Estate 60.72%
2 Technology 6.71%
3 Communication Services 3.62%
4 Consumer Discretionary 3.29%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLAY icon
1051
Relay Therapeutics
RLAY
$3.99B
$6K ﹤0.01%
169
– –
KRTX
1052
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$6K ﹤0.01%
54
+4
+8% +$453
RETA
1053
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$6K ﹤0.01%
62
+8
+15% +$933
FOLD
1054
DELISTED
Amicus Therapeutics
FOLD
$5K ﹤0.01%
490
– –
IBRX icon
1055
ImmunityBio
IBRX
$7.3B
$5K ﹤0.01%
216
+12
+6% +$311
LGND icon
1056
Ligand Pharmaceuticals
LGND
$5.94B
$5K ﹤0.01%
53
+5
+10% +$473
OPK icon
1057
Opko Health
OPK
$1.23B
$5K ﹤0.01%
1,260
-273,000
-100% -$1.3M
RCKT icon
1058
Rocket Pharmaceuticals
RCKT
$343M
$5K ﹤0.01%
120
+16
+15% +$879
XNCR icon
1059
Xencor
XNCR
$1.48B
$5K ﹤0.01%
108
– –
ITCI
1060
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5K ﹤0.01%
151
– –
DCPH
1061
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$5K ﹤0.01%
107
– –
NSTG
1062
DELISTED
NanoString Technologies, Inc.
NSTG
$5K ﹤0.01%
83
– –
RUBY
1063
DELISTED
Rubius Therapeutics, Inc
RUBY
$5K ﹤0.01%
178
– –
GBT
1064
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5K ﹤0.01%
116
– –
AMRN
1065
Amarin Corp
AMRN
$293M
$4K ﹤0.01%
36
– –
AXSM icon
1066
Axsome Therapeutics
AXSM
$12.1B
$4K ﹤0.01%
70
– –
BLUE
1067
DELISTED
bluebird bio
BLUE
$4K ﹤0.01%
10
– –
GRFS
1068
Grifois
GRFS
$5.44B
$4K ﹤0.01%
224
– –
IGMS
1069
DELISTED
IGM Biosciences
IGMS
$4K ﹤0.01%
46
– –
INO icon
1070
Inovio Pharmaceuticals
INO
$84.7M
$4K ﹤0.01%
34
+7
+26% +$921
KURA icon
1071
Kura Oncology
KURA
$826M
$4K ﹤0.01%
131
+24
+22% +$759
MCRB icon
1072
Seres Therapeutics
MCRB
$46.5M
$4K ﹤0.01%
9
– –
MYGN icon
1073
Myriad Genetics
MYGN
$502M
$4K ﹤0.01%
141
– –
RVNC
1074
DELISTED
Revance Therapeutics, Inc.
RVNC
$4K ﹤0.01%
141
+16
+13% +$443
NGM
1075
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4K ﹤0.01%
146
+16
+12% +$448
41 42
43
44 45

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q1 2021 Portfolio in Review

As of Q1 2021, Daiwa Securities Group held 1,308 positions worth $13.4B, up 3.9% from $12.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $544M in Q1 2021, closing 30 positions and reducing 282 holdings. Its most notable exit was Global X Aging Population ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 61% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Daiwa Securities Group opened a new position in Global X Social Media ETF worth $73.4M.

  • Daiwa Securities Group's largest Q1 2021 buy was Global X Social Media ETF: 1,100,000 shares worth $73.4M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q1 2021, an estimated $154M increase.
  • Daiwa Securities Group's biggest Q1 2021 reduction was Simon Property Group, cutting an estimated $187M.
  • Daiwa Securities Group fully exited Global X Aging Population ETF in Q1 2021, selling an estimated $13.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
  • Daiwa Securities Group opened 44 new positions and closed 30 in Q1 2021.
  • Daiwa Securities Group's portfolio value rose 3.9% quarter-over-quarter to $13.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2021, filed 3 May 2021.